As the only proven non-invasive alternative to drugs, ActiveCare+S.F.T. offers the following benefits in the prevention of DVT / VTE:
-
Minimal Use of Anticoagulant Drugs
ActiveCare+S.F.T. is the only device which has supporting data to allow the surgeon to make an informative decision, based on the patient risk as to his/her DVT prevention protocol. Namely: the use of ActiveCare+S.F.T. +/- Aspirin or in conjunction with anticoagulant drugs.
-
Reduced Bleeding Risk
ActiveCare+S.F.T. does not increase the risk of serious bleeding complications.
-
24-Hour Prevention
ActiveCare+S.F.T.
is small and portable allowing patient mobility and 24-hour basis preventative therapy.
-
Reduces Hospital Length of Stay
ActiveCare+S.F.T. can be used both in hospital and in post-discharge at home, which can reduce the patient's length of stay (LOS).
-
Monitors Patient Compliance
ActiveCare+S.F.T. is the only system that routinely monitors patient compliance, providing patients, caregivers and physicians real-time information.
-
User-friendly
ActiveCare+S.F.T. is user-friendly with an LCD screen that provides patient compliance and troubleshooting information.
-
Economicial
ActiveCare+S.F.T. is an economically viable DVT prevention therapy. The system reduces the need for the use of drugs, the amount of blood products and the occurrence of major bleeding complications.